| scholarly article | Q13442814 |
| P356 | DOI | 10.1590/S1677-55382008000200013 |
| P698 | PubMed publication ID | 18462521 |
| P50 | author | Katia R. Leite | Q48836961 |
| Ricardo C Borra | Q60316013 | ||
| P2093 | author name string | Miguel Srougi | |
| Daher C Chade | |||
| Enrico Andrade | |||
| Priscila M Andrade | |||
| Fabiola E Villanova | |||
| P2860 | cites work | Role of animal models in understanding intravesical therapy with bacille Calmette-Guérin | Q34048717 |
| Immunotherapeutic effect of Concholepas hemocyanin in the murine bladder cancer model: evidence for conserved antitumor properties among hemocyanins. | Q34579276 | ||
| Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. | Q35197371 | ||
| The role of immunohistochemistry in the diagnosis of urinary bladder neoplasms | Q36411609 | ||
| Oncolytic viral therapy by bladder instillation using an E1A, E1B double-restricted adenovirus in an orthotopic bladder cancer model | Q40231011 | ||
| Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy. | Q40366972 | ||
| Escape from immune surveillance does not result in tolerance to tumor-associated antigens | Q40524777 | ||
| Use of prostate specific antigen to measure bladder tumor growth in a mouse orthotopic model. | Q45113817 | ||
| Vaccinia virus mediated p53 gene therapy for bladder cancer in an orthotopic murine model | Q45526738 | ||
| Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines | Q45864362 | ||
| Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor Microenvironment | Q45875424 | ||
| AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model | Q45889278 | ||
| Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses. | Q53604999 | ||
| The predictive value of p53, p27(kip1), and alpha-catenin for progression in superficial bladder carcinoma. | Q53640609 | ||
| Establishment and characterization of human urothelial cancer xenografts in severe combined immunodeficient mice. | Q54620098 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 220-6; discussion 226-9 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | International Brazilian Journal of Urology | Q26841933 |
| P1476 | title | Histopathological characterization of a syngeneic orthotopic murine bladder cancer model | |
| P478 | volume | 34 |
| Q38719717 | A Murine Orthotopic Bladder Tumor Model and Tumor Detection System |
| Q33570888 | An orthotopic bladder cancer model for gene delivery studies |
| Q34219595 | Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model |
| Q35580238 | Curcumin, but not Prima-1, decreased tumor cell proliferation in the syngeneic murine orthotopic bladder tumor model |
| Q33962620 | Current animal models of bladder cancer: Awareness of translatability (Review) |
| Q43253959 | Effects of curcumin in an orthotopic murine bladder tumor model |
| Q57036681 | How cancer cells attach to urinary bladder epithelium in vivo: study of the early stages of tumorigenesis in an orthotopic mouse bladder tumor model |
| Q37109988 | Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model |
| Q41339763 | Insights from animal models of bladder cancer: recent advances, challenges, and opportunities |
| Q27346705 | Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment |
Search more.